Pravin L. Kotian - Concepedia

Author

Pravin L. Kotian

BioCryst Pharmaceuticals (United States)ORCID

Also Known As

P. KOTIAN, P. Kotian, P. L. KOTIAN, P. L. Kotian, P.L. Kotian, Pravin Kotian, Pravin L Kotian, Pravin L. Kotian

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

BioCryst Pharmaceuticals (United States)RTI International National Institute on Drug Abuse

About

Pravin L. Kotian is an author at BioCryst Pharmaceuticals (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	1.8K
2	Natural Sciences	9	9	507
3	Biochemistry	7	7	479
4	Engineering	1	1	13
5	Allergy	1	1	36

Pravin L. Kotian

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430 Travis K. Warren, Jay Wells, Rekha G. Panchal, Nature Viral DiagnosticsViral PathogenesisImmunologyAntiviral Drug DevelopmentVirology	2014	597
BCX-1812 (RWJ-270201): Discovery of a Novel, Highly Potent, Orally Active, and Selective Influenza Neuraminidase Inhibitor through Structure-Based Drug Design Y.S. Babu, Pooran Chand, Shanta Bantia, Journal of Medicinal Chemistry Crystal StructureMedicinal ChemistryAntimicrobial Drug DiscoveryDonut IconMedicine	2000	376
Cocaine and 3.beta.-(4'-Substituted phenyl)tropane-2.beta.-carboxylic Acid Ester and Amide Analogs. New High-Affinity and Selective Compounds for the Dopamine Transporter F. Ivy Carroll, Pravin L. Kotian, Ali Dehghani, Journal of Medicinal Chemistry	1995	188
Systematic Structure-Based Design and Stereoselective Synthesis of Novel Multisubstituted Cyclopentane Derivatives with Potent Antiinfluenza Activity Pooran Chand, Pravin L. Kotian, Ali Dehghani, Journal of Medicinal Chemistry Screen MixturesOrganic ChemistryChemistryChemical BiologyActive Stereoisomer	2001	174
Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir Shanta Bantia, Cynthia Parker, Sandya L. Ananth, Antimicrobial Agents and Chemotherapy Medicinal ChemistryDrug DiscoveryInfluenza Virus NeuraminidasePharmacologyAntiviral Drug Development	2001	148
BCX4430, a Novel Nucleoside Analog, Effectively Treats Yellow Fever in a Hamster Model Justin G. Julander, Shanta Bantia, Brian R. Taubenheim, Antimicrobial Agents and Chemotherapy Hamster ModelNovel Nucleoside AnalogYellow FeverPathogenesisMedicine	2014	94
Design and Synthesis of Benzoic Acid Derivatives as Influenza Neuraminidase Inhibitors Using Structure-Based Drug Design Pooran Chand, Y.S. Babu, Shanta Bantia, Journal of Medicinal Chemistry Combinatorial ChemistryBioorganic ChemistryBenzoic Acid DerivativesAntiviral DrugChemical Biology	1997	90
Synthesis, Ligand Binding, and Quantitative Structure−Activity Relationship Study of 3β-(4‘-Substituted phenyl)-2β-heterocyclic Tropanes: Evidence for an Electrostatic Interaction at the 2β-Position Pravin L. Kotian, S. Wayne Mascarella, Philip Abraham, Journal of Medicinal Chemistry	1996	69
Comparison of the anti-influenza virus activity of cyclopentane derivatives with oseltamivir and zanamivir in vivo Pooran Chand, Shanta Bantia, Pravin L. Kotian, Bioorganic & Medicinal Chemistry PharmacologyAntiviral Drug DevelopmentAntiviral TherapyVirologyAnti-influenza Virus Activity	2005	65
Synthesis and Nicotinic Acetylcholine Receptor Binding Properties of <i>exo</i>-2-(2‘-Fluoro-5‘-pyridinyl)-7-azabicyclo- [2.2.1]heptane: A New Positron Emission Tomography Ligand for Nicotinic Receptors Feng‐Xia Liang, Hernán A. Navarro, Philip Abraham, Journal of Medicinal Chemistry Altmetric Attention ScoreMolecular BiologyPharmacotherapyResearch Triangle ParkExperimental Pharmacology	1997	60

Page 1